Tag Archives: Zyprexa

Lilly To See Profit Decline Of Up to One-Third in 2014

Eli Lilly forecasts that its profit will fall by up to one-third this year, Reuters has reported. The company’s forecasted revenue for 2014 is now between $19.2 billion and $19.8 billion, with a net income of $3 billion and operating cash flow of $4 billion. The profit fall is in line with the company’s expectations, […]
Posted in Strategy | Also tagged , , , , | Leave a comment

The Curious Case Of AstraZeneca v. ACE

by Mike Kelly and Andrew Dupre Insurance contracts are a language game that must be played very carefully, as AstraZeneca learned. From 2003 to 2012, AstraZeneca Plc was locked in one of the largest mass tort litigations in the United States, defending its blockbuster second generation atypical antipsychotic product Seroquel from allegations of failure-to-warn of […]
Posted in compliance, Europe, Guest Blog, leadership, Legal, Marketing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta